An Exploratory Study on the Development of Asia-Pacific Specialty Disease and Specialty Medical Centers: A Four-Level Collaborative Pathway and Professional Evaluation Framework

A conceptual study on cross-regional professional collaboration and staged evaluation

Hai Ning

Executive Chair, Asia-Pacific Health Association

Corresponding author: Hai Ning; E-mail: nhapha@163.com

Received: August 11, 2026; Revised: September 28, 2026

Abstract

Objective: To explore the rationale, functional boundaries, staged development pathway, and evaluation framework for Asia-Pacific specialty disease and specialty medical centers, and to provide a conceptual reference for specialty collaboration, health workforce development, research and education, and patient services. Methods: This conceptual framework study analyzes publicly available policy and technical documents from international organizations, including World Health Organization materials on integrated people-centred health services, quality health services, health workforce development, digital health, and artificial intelligence governance, together with public materials on external evaluation in health care. Results: An Asia-Pacific specialty disease and specialty medical center should be understood as an organized professional-capability platform built on legally operating health-care institutions, professional organizations, or collaborative teams, rather than merely as a name, conference brand, or list of experts. A four-level model is proposed: Asia-Pacific Specialty Disease and Specialty Medical Center Joint-Development Institution; Asia-Pacific Specialty Disease and Specialty Medical Center Consortium Institution; Asia-Pacific Specialty Disease and Specialty Medical Center with One or Several Functions; and Asia-Pacific Specialty Disease and Specialty Medical Center with Full Functions. Conclusion: Using specialty-center development as a common framework may help transform fragmented institutional, professional, conference, research, education, membership, and digital-health resources into sustainable professional collaboration. Implementation requires evidence-based progression, staged development, and clear separation between professional evaluation, medical practice authorization, governmental licensing, and statutory accreditation.

Keywords: Asia-Pacific; specialty disease; specialty medical center; regional collaboration; staged evaluation; health workforce development; quality of care

1. Introduction

Countries and territories across the Asia-Pacific region differ substantially in health-care resources, specialty capacity, disease profiles, medical education, and health governance. Some specialty fields have developed clinical and academic foundations, yet institutional collaboration, workforce development, research and education, patient referral, and quality improvement may remain fragmented. Cooperation may depend on individual experts, temporary meetings, or short-term projects, making it difficult to establish a stable, traceable, and sustainable professional collaboration mechanism.

The World Health Organization’s framework for integrated, people-centred health services emphasizes organizing services around people’s life-course needs, coordinating different providers and service settings, strengthening governance and accountability, and promoting continuity and cross-sector collaboration [1-2]. This perspective provides an important reference for moving specialty disease and specialty medical centers from isolated functions toward organized collaboration platforms.

This article does not evaluate the clinical effectiveness of a particular disease program or medical institution. Instead, it presents a conceptual study of the development rationale, functional structure, staged pathway, and evaluation boundaries of Asia-Pacific specialty disease and specialty medical centers, with the aim of providing a discussable foundation for subsequent pilots and system improvement.

2. Methods and Sources

This study uses a conceptual framework approach and consists of three parts. First, it conducts thematic analysis of publicly available documents issued by international organizations concerning integrated people-centred health services, quality of care, health workforce development, digital health, and artificial intelligence governance. Second, it reviews public materials on external evaluation in health care, including the boundaries between evaluation, certification, accreditation, regulation, and licensing. Third, it combines these materials with the proposed development framework for Asia-Pacific specialty disease and specialty medical centers and organizes the results by organizational entity, functional module, evidence requirement, and compliance boundary.

The global public sources used in this article are drawn from official websites or formally published materials of relevant international organizations. The four-level model proposed here is a conceptual proposal developed by the author on the basis of those sources; it should not be presented as a system already endorsed by the World Health Organization, ISQua, or any other international organization.

3. Rationale for Development

3.1 Responding to the need for continuous specialty services

Chronic diseases, rare diseases, complex pediatric conditions, and other long-term specialty services commonly involve screening, diagnosis, treatment, rehabilitation, follow-up, patient education, and family support. The World Health Organization emphasizes that integrated, people-centred care should be organized around people’s comprehensive needs and continuity of care rather than around a single disease or institution [1]. Specialty-center development therefore needs to focus on service chains and coordination mechanisms rather than simply adding a new name.

3.2 Promoting cross-regional professional collaboration

Cross-border or cross-regional health cooperation may include patient referral, health-worker exchange and training, professional knowledge sharing, remote consultation, testing, and information coordination [6]. An Asia-Pacific specialty disease and specialty medical center may serve as a professional collaboration vehicle, but diagnosis, treatment, referral decisions, and patient-safety responsibilities must remain with appropriately licensed medical institutions and qualified professionals under applicable law.

3.3 Turning fragmented resources into coordinated capacity

When associations, hospitals, professional committees, expert teams, and social resources operate independently over the long term, conferences, training, membership development, research, and patient services can become disconnected. Using specialty-center development as a common framework can bring these activities into a unified professional-development and quality-improvement structure.

3.4 Responding to changes in the health workforce

The World Health Organization’s global strategy on human resources for health emphasizes the availability, accessibility, acceptability, quality, and sustainable development of health workers [3]. In addition to clinicians, modern specialty centers require nursing and rehabilitation professionals, quality and patient-safety personnel, data-governance and artificial-intelligence personnel, research and education personnel, international-collaboration personnel, and legal and compliance personnel.

4. Concept and Scope

An Asia-Pacific specialty disease and specialty medical center is an organized professional-capability platform established around a defined specialty, disease area, or population group and supported by legally operating hospitals, professional organizations, or collaborative teams. Its core is not the name or logo, but a professional capability system that can operate continuously and be subject to review.

1. Define the target population, specialty scope, and exclusions;

2. Identify a real host entity, responsible person, and authorization relationship;

3. Establish a multidisciplinary or cross-professional collaboration mechanism;

4. Form actual functions such as training, consultation, research, education, referral coordination, or other documented services;

5. Clarify responsibilities for medical quality, patient safety, data, and privacy;

6. Establish quality indicators, evidence records, and continuous-improvement mechanisms;

7. Develop bilingual and cross-cultural communication capacity appropriate to Asia-Pacific cooperation;

8. Accept annual operational confirmation, professional evaluation, and necessary corrective review.

Conferences, expert lists, equipment numbers, membership status, or payment records cannot by themselves prove that a medical center has been established.

5. Four-Level Development Framework

Level	Name	Main functions	Boundary of result
Level 1	Asia-Pacific Specialty Disease and Specialty Medical Center Joint-Development Institution	Confirm the entity, responsible person, specialty direction, intention, and cooperation boundaries	No title issuance; does not represent a medical license or accreditation
Level 2	Asia-Pacific Specialty Disease and Specialty Medical Center Consortium Institution	Confirm membership relationships, cooperation matters, and collaboration responsibilities	Forms a consortium operating identity
Level 3	Asia-Pacific Specialty Disease and Specialty Medical Center with One or Several Functions	Operate verified functions such as training, consultation, research, education, or other approved functions	Confirms only the verified functional scope
Level 4	Asia-Pacific Specialty Disease and Specialty Medical Center with Full Functions	Establish integrated operation, quality improvement, and a multi-function collaboration system	Professional-capability evaluation result of the Association

The first level is the participation entry point, the second level is consortium operation, the third level is functional development, and the fourth level is integrated operation. A subsequent statutory certification mechanism is not established at this stage and is outside the current development framework; if it is to be studied in the future, it should be addressed separately. A consortium is a professional collaboration platform and is not equivalent to a statutory medical consortium established by a mainland Chinese health administrative authority.

6. Major Functional Modules

· Specialty collaboration and multidisciplinary exchange;

· Health workforce training, continuing learning, and role development;

· Academic and technical exchange among hospitals and professional organizations;

· Expert consultation and, where necessary, patient referral coordination;

· Research cooperation, data research, and translation of results;

· Educational activities, case discussion, and knowledge dissemination;

· Specialty data governance, quality indicators, and continuous improvement;

· Artificial-intelligence-assisted applications, information interoperability, and human review;

· Patient education, family support, and long-term management;

· International and Asia-Pacific regional cooperation.

Digital health and artificial intelligence should function as support tools and must not replace the clinical judgment, accountability, or patient communication of legally qualified professionals. The World Health Organization emphasizes that digital interventions are not substitutes for a complete health system and that artificial-intelligence applications require accountability, responsibility, transparency, fairness, and human oversight [4-5].

7. Health Workforce Development

A specialty center should establish a panoramic workforce system that includes professional technical personnel, nursing and continuous-care personnel, quality and patient-safety personnel, research and education personnel, data-governance and artificial-intelligence personnel, international-collaboration personnel, project-management personnel, patient-service personnel, and legal and compliance personnel.

Workforce evaluation should not rely solely on job titles, academic honors, or expert lists. It should also consider actual work records, professional contributions, collaboration capacity, teaching ability, research results, quality-improvement outcomes, and sustained participation. Cross-regional cooperation additionally requires bilingual communication, cross-cultural competence, information management, and conflict-of-interest management.

8. Evaluation Mechanisms and Compliance Boundaries

External evaluation is commonly distinguished from evaluation, certification, accreditation, regulation, and licensing. ISQua’s terminology principles indicate that external evaluation is an umbrella concept that may include different forms such as certification, accreditation, regulation, and licensing [7]. Accordingly, the Association’s professional activities should use terms such as “confirmation,” “evaluation,” “directory registration,” and “annual review” with precision, and should not use statutory certification, government authorization, or national accreditation language before the relevant qualifications and procedures exist.

1. The evaluation subject must genuinely exist, with clear identity, scope, responsible persons, and responsibility boundaries;

2. Evaluation results apply only to the specified specialty, institution, location, and regional scope;

3. Professional evaluation by the Association is not equivalent to government licensing, medical-practice qualification, or statutory accreditation;

4. Consultation, diagnosis, treatment, referral, and patient-safety responsibilities remain with legally operating medical institutions and qualified professionals;

5. Continuing medical education credits may be recognized only by appropriately qualified program entities and competent authorities;

6. Fees, membership status, conference attendance, or expert recommendations must not substitute for professional evidence;

7. Traditional Chinese medicine, domestically manufactured equipment, and consumables may be evaluated according to disease suitability, safety, quality, traceability, and innovation, but no blanket barrier may be created for a designated brand or origin;

8. Statutory accreditation matters must be arranged separately only when the relevant legal, organizational, procedural, personnel, evidence, and accountability systems are mature.

9. Development Pathway

Stage	Main tasks	Result
Stage 1	Identify needs, conduct an institutional and workforce inventory, and confirm cooperation boundaries	Enter the joint-development institution directory
Stage 2	Form member relationships, cooperation projects, an annual plan, and expert interaction	Form a consortium institution operating identity
Stage 3	Select one or several functions, operate them in practice, and retain evidence	Apply for confirmation of one or several functions
Stage 4	Improve governance, quality, workforce, data, international cooperation, and continuous improvement	Apply for full-function evaluation

10. Discussion

The value of developing Asia-Pacific specialty disease and specialty medical centers does not lie in adding another title, but in establishing a sustainable professional collaboration system. The key is to connect dispersed people, institutions, conferences, research, education, and patient-service needs, while using clear evidence and responsibility boundaries to ensure that the system operates in practice.

The Association should use professional evaluation as a coordination tool rather than as government administrative evaluation, and should avoid equating conferences, membership, and publicity activities with medical-center capability. It should also avoid high-risk claims such as “internationally leading” or “the only regional center” when evidence is insufficient. Only staged development, evidence-based evaluation, clear accountability, and progressive implementation can produce a credible and sustainable regional specialty collaboration system.

11. Conclusion

The development of Asia-Pacific specialty disease and specialty medical centers may become an important mechanism for advancing regional medical collaboration, health workforce development, research and education, patient services, and Association resource integration. The four-level development framework provides institutions and professionals with a pathway for gradual participation, operation, and evaluation. The next step should prioritize pilot projects in specialty fields with sound professional foundations, clear needs, and well-defined risk boundaries, while continuously improving the framework through operational evidence, quality indicators, and annual review.

Conflict of Interest Statement

The author declares no conflict of interest related to this article.

Ethics Statement

This is a policy and framework study and does not involve personal information, clinical trials, or human-subject research data.

Funding

No specific funding was received for this work.

Author Contribution

Hai Ning was responsible for the conceptual framework, source organization, system analysis, and manuscript preparation.

References

[1] World Health Organization. Integrated people-centred care[EB/OL]. Geneva: WHO. https://www.who.int/health-topics/integrated-people-centered-care

[2] World Health Organization. Framework on integrated people-centred health services: overview[R]. Geneva: WHO, 2016. https://www.who.int/docs/default-source/integrated-health-services-(ihs)/csy/ipchs/ipchs_overview.pdf

[3] World Health Organization. Global strategy on human resources for health: Workforce 2030[R]. Geneva: WHO, 2020. https://www.who.int/publications/i/item/9789241511131

[4] World Health Organization. WHO guideline: recommendations on digital interventions for health system strengthening[R]. Geneva: WHO, 2019. https://www.who.int/publications-detail-redirect/9789241550505

[5] World Health Organization. Ethics and governance of artificial intelligence for health[R]. Geneva: WHO, 2021. https://www.who.int/publications/i/item/9789240029200

[6] World Health Organization Regional Office for Europe. Cross-border collaboration in the field of health care: the approach of the Healthacross Initiative in Lower Austria[R]. Copenhagen: WHO Regional Office for Europe, 2024. https://iris.who.int/handle/10665/378548

[7] International Society for Quality in Health Care. ISQua's terminology principles[EB/OL]. Dublin: ISQua, 2018. https://isqua.org/isqua-s-terminology-principles/

[8] World Health Organization. Quality health services: a planning guide[R]. Geneva: WHO, 2020. https://www.who.int/publications/i/item/9789240011632

[9] World Health Organization. Classification of digital interventions, services and applications in health, 2nd ed[R]. Geneva: WHO, 2023. https://www.who.int/publications/i/item/9789240081949